Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in ISOLF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ISOLF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for ISOLF.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 900.0 | 0.0 | 0.0 | +900.0% |
| 2024 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2023 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2022 | 0.0 | -50.0 | 0.0 | 100.0 | 0.0 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | -80.0 | −90.0% |
| 2021 | 167.9 | 30.0 | -31.7 | 5.1 | -14.6 | -31.4 | -14.6 | 28.6 | 11.1 | -97.2 | 185.7 | -97.5 | −99.6% |
| 2020 | 30.9 | -25.7 | -37.3 | -39.2 | 12.1 | -7.5 | -14.7 | -23.3 | -23.0 | -29.1 | -5.6 | 64.7 | −78.6% |
| 2019 | 33.0 | -9.6 | 6.2 | -25.7 | 2.7 | -12.6 | -65.2 | -6.3 | -27.0 | -8.1 | -9.1 | -17.6 | −86.1% |
| 2018 | 6.1 | -18.1 | -7.4 | -26.2 | -27.1 | -21.3 | -20.0 | -11.8 | 13.7 | -56.7 | -1.7 | -23.6 | −91.1% |
| 2017 | 53.2 | -8.0 | -16.7 | -4.3 | -11.5 | 77.1 | 82.6 | -21.9 | -13.0 | -1.2 | 433.6 | -6.4 | +978.1% |
| 2016 | 0.0 | -83.0 | -34.0 | -15.8 | -0.1 | 33.3 | 65.8 | -5.4 | -10.5 | 82.8 | -43.7 | -43.6 | −89.7% |
| 2015 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2014 | 0.0 | 0.0% |
No analyst coverage for this instrument.
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.
No recent headlines.